These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7377218)

  • 1. Research design: general designs.
    Mikeal RL
    Am J Hosp Pharm; 1980 Apr; 37(4):541-8. PubMed ID: 7377218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allocation of patients to treatment in clinical trials.
    Pocock SJ
    Biometrics; 1979 Mar; 35(1):183-97. PubMed ID: 497334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover and self-controlled designs in clinical research.
    Louis TA; Lavori PW; Bailar JC; Polansky M
    N Engl J Med; 1984 Jan; 310(1):24-31. PubMed ID: 6689736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General purpose of research designs.
    Jang R
    Am J Hosp Pharm; 1980 Mar; 37(3):398-403. PubMed ID: 7369224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balanced designs for multiple crossover studies.
    Gaus W; Högel J
    Arzneimittelforschung; 1992 Feb; 42(2):163-72. PubMed ID: 1610429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sampling: how to fix the odds--Part 3.
    How Eval Health Programs; 1980 Sep; 3(9):1-5. PubMed ID: 10248054
    [No Abstract]   [Full Text] [Related]  

  • 8. Sampling: how to fix the odds--Part 2.
    How Eval Health Programs; 1980 Aug; 3(8):1-7. PubMed ID: 10248053
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research designs and levels of evidence].
    Aartman IH; van Loveren C
    Ned Tijdschr Tandheelkd; 2007 Apr; 114(4):161-5. PubMed ID: 17484412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward an experimental chiropractic: time-series designs.
    Keating JC; Giljum K; Menke JM; Lonczak RS; Meeker WC
    J Manipulative Physiol Ther; 1985 Dec; 8(4):229-38. PubMed ID: 4078502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomization tests for multiple-baseline designs: an extension of the SCRT-R package.
    Bulté I; Onghena P
    Behav Res Methods; 2009 May; 41(2):477-85. PubMed ID: 19363188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurse staffing level and nosocomial infections: empirical evaluation of the case-crossover and case-time-control designs.
    Hugonnet S; Villaveces A; Pittet D
    Am J Epidemiol; 2007 Jun; 165(11):1321-7. PubMed ID: 17400571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-manipulation quantitative designs.
    Rumrill PD
    Work; 2004; 22(3):255-60. PubMed ID: 15156091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuously distributed random variables in factorial designs.
    Bell RW
    Exp Aging Res; 1992; 18(1-2):47-50. PubMed ID: 1446695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover designs with correlated observations.
    Donev AN
    J Biopharm Stat; 1998 May; 8(2):249-62. PubMed ID: 9598421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic components in the development of research proposals in health sciences].
    Suárez Pérez EL; Pérez Cardona CM
    P R Health Sci J; 1999 Jun; 18 Suppl A():i-iv, 1-49. PubMed ID: 10464912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general method for describing sources of variance in clinical trials, especially operator variance, in order to improve transfer of research knowledge to practice.
    Chambers DW; Leknius C; Reid L
    J Prosthodont; 2009 Apr; 18(3):265-71. PubMed ID: 19141049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some methodological questions about randomizing collective units (author's transl)].
    Padieu R
    Rev Epidemiol Sante Publique; 1981; 29(3):255-68. PubMed ID: 7302310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.